Venture Capital Investors

Cumulus Oncology

VC firm Cumulus Oncology invests in high-potential tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Europe's first oncology biotech creation studio, Cumulus Oncology was founded by Dr Clare Wareing (CEO) in 2017. Underpinning the creation of Cumulus was the evident inherent redundancy in the traditional biotech model. Cumulus companies are managed to key value inflection points and assigned team members appropriate to the scientific area and development stage of each company. This also includes business leaders experienced in biotech fundraising. Our mission is to accelerate oncology innovation into world changing impact

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/7/2023

Transaction History

Our records indicate that Cumulus Oncology invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Operating Officer

Clare Doris

        

Chairman

Russell Greig

        

Chief Financial Officer

Keith Murdoch

        

Chief Executive Officer

Clare Wareing

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Cumulus Oncology has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Cumberland | Cuna del Mar

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary